![]() |
市场调查报告书
商品编码
1933101
全球男性活力和睪固酮支持类快速消费品市场预测(至2032年),按产品类型、成分类型、配方、分销管道、最终用户和地区划分Men's Vitality & Testosterone Support FMCG Market Forecasts to 2032 - Global Analysis By Product Type, Ingredient Type, Formulation, Distribution Channel, End User and By Geography |
||||||
根据 Stratistics MRC 的一项研究,预计到 2025 年,全球男性活力和睪固酮支持快速消费品市场价值将达到 69.3 亿美元,在预测期内以 10.1% 的复合年增长率增长,到 2032 年将达到 136 亿美元。
男性活力与睪固酮支持类快速消费品(FMCG)是指旨在提升男性能量、耐力、肌肉健康、性慾、情绪和维持健康睪固酮水平的消费品。此类别包括膳食补充剂、机能性食品和饮料、强化营养产品以及使用维生素、矿物质、植物萃取物、蛋白质和适应原的个人健康产品。这些产品专为日常使用而设计,强调便利性、安全性和循证有效性,通常采用洁净标示。它们透过便利的零售通路销售,目标客户是希望提升运动表现、平衡新陈代谢、延缓老龄化并改善整体健康状况的成年男性,产品销往全球线上线下市场。
对性腺功能减退症的认识提高
荷尔蒙检测和健康筛检准确性的提高提高了诊断率,并鼓励男性积极主动地管理自身荷尔蒙健康。媒体通报、数位健康平台和健康领域的意见领袖正在向消费者普及疲劳、性慾低下和肌肉流失等症状。预防性医疗保健的趋势促使男性消费者倾向于选择营养补充剂而非处方笺药。医疗保健专业人员也越来越多地推荐以生活方式为基础的睾酮支持产品作为辅助治疗手段。男性健康诊所和远端医疗咨询的普及也提高了男性获得荷尔蒙相关指导的途径。
高昂的製造成本和合规成本
製造商必须遵守多个地区的严格食品安全标准、原材料可追溯性规范和标籤法规。使用经临床验证的成分,例如草药萃取物、维生素和生物活性化合物,会显着增加采购和配方成本。符合GMP、ISO和洁净标示标准等认证要求可进一步增加营运成本。小规模品牌在扩大生产规模的同时,往往难以维持合规性和品质一致性。有关健康声明的法规频繁更新,也增加了产品核可和市场准入的复杂性。这些成本压力会限制创新并降低价格竞争力,尤其是在新兴市场。
个人化营养与人工智慧
人工智慧驱动的平台使品牌能够根据年龄、生活方式、生物标记和荷尔蒙水平提供客製化的营养补充剂建议。数据分析和穿戴式健康设备的进步正在改善对健身、睡眠和代谢指标的即时追踪。消费者越来越倾向于寻求更个人化的解决方案来满足其独特的活力需求,而不是千篇一律的处方。个人化的订阅营养模式有助于提高客户参与和长期品牌忠诚度。人工智慧与营养基因组学的融合为精准睪酮支持产品开闢了新的可能性。这种向个人化的转变预计将重塑整个产业的产品开发和行销策略。
仿冒品/含有非法添加物的产品
含有未申报药物成分的未经监管产品会损害消费者信任和品牌信心。线上市场和跨境电商通路的激增增加了仿冒品流入消费者手中的风险。这些低品质的替代品往往模仿知名公司的包装和品牌,造成市场混乱。监管机构在监控数位销售平台和非正规分销网路方面面临挑战。反覆出现的安全问题导致监管更加严格,甚至对合规的製造商也造成了影响。因此,打击仿冒品品需要增加对防伪技术和供应链透明度的投资。
新冠疫情对男性活力和睪固酮支持类快速消费品市场产生了复杂的影响。疫情初期的封锁措施扰乱了原料采购、生产营运和全球物流网络。随着健身房和医疗机构准入限制的逐步解除,男性开始在家中进行健康和营养补充。随着消费者转向线上购买健康产品,电子商务通路经历了显着成长。各大品牌加速推动数位化行销和直销策略,以维持市场占有率。疫情后,市场正优先考虑增强韧性、实现供应链多元化以及采用数位化优先的互动模式。
预计在预测期内,营养补充品细分市场将占据最大的市场份额。
由于膳食补充剂具有方便、价格实惠和产品种类繁多等优点,因此预计在预测期内,膳食补充剂领域将占据最大的市场份额。胶囊、片剂、粉末和软糖等形式的补充剂可以轻鬆融入日常生活。消费者对天然植物性睪固酮增强剂的日益偏好正在推动其普及。含有锌、维生素D、镁和草药萃取物的临床验证配方也增强了产品的可信度。积极的行销、名人代言以及与运动营养领域的整合也进一步推动了销售。
在预测期内,老年人群将呈现最高的复合年增长率。
预计在预测期内,老年人群将呈现最高的成长率,这主要得益于老年男性对睪固酮支持和活力增强产品的需求。预期寿命的延长促使男性更专注于保持体力、耐力和性功能。老年消费者更愿意投资预防性健康解决方案,以维持生活品质。人们对男性更年期和与老龄化相关的代谢变化的认识不断提高,推动了相关产品的普及。医疗保健专业人员也越来越多地建议老龄化男性在改变生活方式的同时,进行营养干预。
预计北美将在预测期内占据最大的市场份额,这主要得益于消费者对荷尔蒙健康和预防保健的高度关注。该地区拥有强大的购买力,且优质保健产品供应充足。完善的膳食补充剂监管法规提升了消费者对产品安全性和有效性的信心。透过数位平台和健身日常消费品进行的广泛行销也推动了市场扩张。大型快速消费品和营养保健品公司的入驻正在推动创新和产品多元化。
预计亚太地区在预测期内将实现最高的复合年增长率。快速的都市化和生活方式的改变加剧了男性压力水平和代谢健康问题。可支配收入的成长推动了男性在健康和营养补充剂产品上的支出。在数位健康宣传活动的支持下,人们对男性健康议题的认识不断提高,促进了相关产品的普及。电子商务和直销通路的扩张提高了全部区域产品的可及性。本地製造商正在推出采用传统草药成分、符合当地文化习惯的配方。
According to Stratistics MRC, the Global Men's Vitality & Testosterone Support FMCG Market is accounted for $6.93 billion in 2025 and is expected to reach $13.60 billion by 2032 growing at a CAGR of 10.1% during the forecast period. Men's Vitality & Testosterone Support FMCG refers to fast-moving consumer goods formulated to support male energy, stamina, muscle health, libido, mood, and healthy testosterone levels. The category spans supplements, functional foods and beverages, fortified nutrition, and personal wellness products using vitamins, minerals, botanicals, proteins, and adaptogens. Positioned for everyday use, these products emphasize convenience, safety, and evidence-backed benefits, often featuring clean-label claims. They target adult men seeking performance, metabolic balance, healthy aging, and overall wellbeing through accessible retail channels globally across online and offline markets.
Rising awareness of hypogonadism
Increased diagnosis rates, supported by improved hormonal testing and health screenings, are encouraging men to proactively manage hormonal health. Media coverage, digital health platforms, and wellness influencers are educating consumers about symptoms such as fatigue, reduced libido, and muscle loss. Preventive healthcare trends are shifting male consumers toward nutritional solutions rather than prescription therapies. Healthcare professionals are also increasingly recommending lifestyle-based testosterone support products as complementary interventions. The expansion of men's wellness clinics and telehealth consultations has improved accessibility to hormone-related guidance.
High production & compliance costs
Manufacturers must adhere to stringent food safety standards, ingredient traceability norms, and labeling regulations across multiple geographies. The use of clinically backed ingredients such as herbal extracts, vitamins, and bioactive compounds significantly increases sourcing and formulation expenses. Compliance with certifications such as GMP, ISO, and clean-label standards further raises operational costs. Smaller brands often face challenges in scaling production while maintaining regulatory alignment and quality consistency. Frequent regulatory updates related to health claims add complexity to product approvals and market entry timelines. These cost pressures can limit innovation and reduce price competitiveness, particularly in emerging markets.
Personalized nutrition & AI
AI-driven platforms are enabling brands to offer customized supplement recommendations based on age, lifestyle, biomarkers, and hormonal profiles. Advances in data analytics and wearable health devices are improving real-time tracking of fitness, sleep, and metabolic indicators. Consumers are increasingly seeking tailored solutions rather than generic formulations to address individual vitality needs. Subscription-based personalized nutrition models are enhancing customer engagement and long-term brand loyalty. Integration of AI with nutrigenomics is opening new possibilities for precision testosterone support products. This shift toward personalization is expected to reshape product development and marketing strategies across the sector.
Counterfeit & adulterated products
Unregulated products containing undeclared pharmaceutical substances can undermine consumer trust and brand credibility. Online marketplaces and cross-border e-commerce channels have made it easier for counterfeit products to reach consumers. These low-quality alternatives often mimic packaging and branding of established companies, creating market confusion. Regulatory authorities face challenges in monitoring digital sales platforms and informal distribution networks. Repeated safety concerns can trigger stricter regulations, impacting compliant manufacturers. As a result, combating counterfeiting requires increased investment in authentication technologies and supply chain transparency.
The COVID-19 pandemic had a mixed impact on the men's vitality and testosterone support FMCG market. Initial lockdowns disrupted raw material sourcing, manufacturing operations, and global logistics networks. Reduced access to gyms and clinical consultations encouraged men to adopt at-home wellness and supplementation routines. E-commerce channels witnessed strong growth as consumers shifted toward online purchasing of health products. Brands accelerated digital marketing and direct-to-consumer strategies to maintain market presence. Post-pandemic, the market is emphasizing resilience, supply chain diversification, and digital-first engagement models.
The dietary supplements segment is expected to be the largest during the forecast period
The dietary supplements segment is expected to account for the largest market share during the forecast period, due to its convenience, affordability, and wide product availability. Supplements such as capsules, tablets, powders, and gummies are easily integrated into daily routines. Increasing preference for natural and plant-based testosterone boosters is strengthening consumer adoption. Clinically supported formulations containing zinc, vitamin D, magnesium, and herbal extracts are gaining credibility. Aggressive marketing, celebrity endorsements, and sports nutrition cross-over appeal are further driving sales.
The aging population segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the aging population segment is predicted to witness the highest growth rate, due to demand for testosterone support and vitality-enhancing products among older men. Increased life expectancy is encouraging men to focus on maintaining strength, stamina, and sexual health. Older consumers are more willing to invest in preventive wellness solutions to sustain quality of life. Rising awareness of andropause and age-related metabolic changes is boosting product adoption. Healthcare professionals are increasingly recommending nutritional interventions alongside lifestyle modifications for aging men.
During the forecast period, the North America region is expected to hold the largest market share, due to high consumer awareness regarding hormonal health and preventive wellness. The region benefits from strong purchasing power and widespread availability of premium health products. Well-established dietary supplement regulations enhance consumer confidence in product safety and efficacy. Extensive marketing through digital platforms and fitness communities supports market expansion. Presence of leading FMCG and nutraceutical companies drives innovation and product diversification.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. Rapid urbanization and lifestyle changes are increasing stress levels and metabolic health concerns among men. Rising disposable incomes are enabling higher spending on wellness and nutritional products. Growing awareness of men's health issues, supported by digital health campaigns, is driving product adoption. Expansion of e-commerce and direct-to-consumer channels is improving product accessibility across the region. Local manufacturers are introducing culturally tailored formulations using traditional herbal ingredients.
Key players in the market
Some of the key players in Men's Vitality & Testosterone Support FMCG Market include GNC Holdings, Inc., GlaxoSmithKline plc (GSK), Herbalife Nutrition Ltd., Vitabiotics Ltd., Amway Corporation, Optimum Nutrition, Inc., Pfizer Inc., Blackmores Limited, Bayer AG, Iovate Health Sciences International Inc., NOW Foods, Swisse Wellness Pty Ltd., Nature's Bounty Co., Sanofi S.A., and Abbott Laboratories.
In January 2026, Abbott announced collaboration with AtaCor Medical to advance a next-generation investigational extravascular implantable cardioverter defibrillator (EV-ICD) system designed to deliver defibrillation therapy to people with life-threatening heart rhythms.
In September 2025, Pfizer Inc. announced it has entered into an exclusive global collaboration and license agreement with YaoPharma, a subsidiary of Shanghai Fosun Pharmaceutical Co., Limited, a leading innovation-driven global healthcare company, for the development, manufacturing and commercialization of YP05002, a small molecule glucagon-like peptide 1 (GLP-1) receptor agonist currently in Phase 1 development for chronic weight management.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.